Touchstone International Medical Science Co (688013) Fair Value & Analysis
Healthcare · CN · Market cap 2.2B CNY
Fair value as of: Jun 24, 2026
Analysis
Touchstone International Medical Science Co (688013) currently trades at ¥27.19, while our model-based Fair Value estimate is ¥20.52 — implying the stock looks roughly 24.5% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Touchstone International Medical Science Co., Ltd. researches and develops, manufactures, and sells medical devices in China, the United States, Europe, Japan, Russia, Brazil, South Korea, Canada, Australia, and internationally. It provides laparoscopic, tube-type, intraluminal, endoscopic linear cutters and reloads, linear cutters and reloads, auto purse string clamps, and linear staplers and reloads, as well as proctological, circumcision, and circular staplers. It offers its products for use in laparoscopic and open surgeries. The company was founded in 2003 and is based in Suzhou, the People's Republic of China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Touchstone International Medical Science Co (688013) undervalued?
What is the fair value of 688013?
What is the quality score of 688013?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.